Antioxidant effects of immunomodulators in patients with recurrent pyelonephritis

Abstract

The purpose of our work was to investigate the effect of immunomodulatory medicines on the intensity of oxidative stress (OS), the cytokines level and the activity of renospecific enzymes in patients with recurrent pyelonephritis (rPN). Methods. A prospective, randomized, open-label study involved of 100 women aged 33.4 ± 8.8 year old. According to the sensitivity of the detected pathogens all patients received antibacterial therapy for two weeks. Along with the main course of antibiotic therapy, 25 patients were assigned Sodium nucleinate at a dose of 0.25 g 4 times per day during 14 days, 18 patients were prescribed Galavit intramuscularly 2 ml per dayfor 10 days, and 27patients were prescribed Proteflazid according to the manufacturer’s instructions. The comparison group consisted of 30 women with rPN who received antibiotic therapy exclusively.Women were screened before and after the treatment. The content of malondialdehyde (MDA), ceruloplasmin (CP), transferrin (TF) and sulfhydryl groups (SH-groups) were determined in the blood by colorimetric method. Oxidative stress index (OSI) was calculated. The concentration of interleukins (IL) -1f, -4, -8, -10, -17, tumor necrosis factor a (TNF-a), transforming growth factor f (TGF-f), monocytic chemoactive protein-1 (MCP-1) and interferon y (IFN-y) were analyzed in the blood of the women using an ELISA. To evaluate the functional state of the renal parenchyma the activity of tubular lysosome enzymes a total f-N-acetylhexosaminidase and f-galactosidase were determined in urine. Results. The use of Sodium nucleinate decreased of the OS activity by reducing MDA level (p <0.001) and increasing the concentration of CP (p < 0.03). The serum levels ofIL-4 (p = 0.007), lL-17 (p = 0.04), TGF-f (p = 0.02) and MCP-1 (p = 0.03) were decrease. The use of Galavit contributed to a statistically significant decrease in the concentration of TNF-a (p <0.001), IL-8(p <0.001), IFN-y (p = 0.001) and TGF-f (p <0.001). The administration of Proteflazid resulted in a decrease in the concentrations of IL-8 and IFN-y, with a decrease in OSI (p =0.04) compared to pre-treatment. All applied immunomodulators partially reduced the activity of renospecific enzymes markers of kidney damage. Conclusions. The use of immunomodulators in the complex therapy of patients with rPN contributes to the partial normalization of functional activity of immune system by the decreasing ofthe production ofcytokines as its mediators and the reducing ofthe OS intensity.

Authors and Affiliations

M. Kolesnyk, L. V. Korol, N. M. Stepanova, V. Driianska, L. Ya. Migal

Keywords

Related Articles

МОРФОФУНКЦИОНАЛЬНОЕ СОСТОЯНИЕ ПОЧЕК КРЫС ПОСЛЕ ВВЕДЕНИЯ КРИОЭКСТРАКТА ПЛАЦЕНТЫ ПРИ НЕФРИТЕ ХЕЙМАНА

Изучение иммунного механизма поражения почек на модели нефрита Хеймана (НХ), вызывающего изменения сосудов почечных клубочков, их морфологических и морфометрических показателей, представляют значительный интерес Цель ра...

System inflammation and protein energy wasting correction in patients with chronic kidney disease

Protein-energy wasting as a manifestation of nutritional disorders is one of the central complications in chronic kidney disease (CKD) and largely determines quality and life expectancy. Both decrease in nutritional stat...

ПРЕДИКТОРИ ХРОНІЧНОЇ ХВОРОБИ НИРОК У ПАЦІЄНТІВ, ІНФІКОВАНИХ ВІРУСОМ ІМУНОДЕФІЦИТУ ЛЮДИНИ

Мета роботи: встановити частоту діагностики та предиктори хронічної хвороби нирок у ВІЛ- інфікованих пацієнтів. Пацієнти та методи. Обстежено 292хворих на ВІЛ-інфекцією, які перебували на амбулаторному спостереженні в Ч...

THE MODERN VIEWS TO DIAGNOSIS OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION FOR EARLY PREVENTION

The article discusses in detail the problem of the medico-social significance of early kidney damage in essential hypertension (EH) (according to the literature review and own research). Aim. To determine the prevalence...

Інноваційні напрямки превенції та лікування хворих на ХХН

Хронічна хвороба нирок (ХХН) є глобальною проблемою охорони здоров’я. Наявна ХХН значно під-вищує частоту летальних наслідків незалежно від причин загалом, і особливо від кардіоваскулярних ускладнень зокрема. Основна пр...

Download PDF file
  • EP ID EP353195
  • DOI 10.31450/ukrjnd.2(58).2018.04
  • Views 102
  • Downloads 0

How To Cite

M. Kolesnyk, L. V. Korol, N. M. Stepanova, V. Driianska, L. Ya. Migal (2018). Antioxidant effects of immunomodulators in patients with recurrent pyelonephritis. УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ, 2(58), 18-28. https://europub.co.uk/articles/-A-353195